Cao, X., Xia, H.Y., Zhang, T., Qi, L.C., Zhang, B.Y., Cui, R., Chen, X., Zhao, Y.R. and Li, X.Q. (2015) Protective Effect of Lyophilized Recombinant Human Brain Natriuretic Peptide on Renal Ischemia/Reperfusion Injury in Mice. Genetics and Molecular Research, 14, 13300-13311.
https://doi.org/10.4238/2015.October.26.26

has been cited by the following article:

• TITLE: Forskolin Modulates the Inhibitory Effect of C-Type Natriuretic Peptide on Hypoxia-Induced Atrial Dynamics and Hypoxia Inducible Factor 1 Alpha Activity

  AUTHORS: Chengming Guan, Yanan Jia, Chaochao Bian, Bo Zhang, Dazhi Ding, Xun Cui

  KEYWORDS: C-Type Natriuretic Peptide, Hypoxia Inducible Factor-1α, Phosphodiesterase, Adenylyl Cyclase, Forskolin

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.5 No.1, January 3, 2017

  ABSTRACT: Our study investigated effects of C-type natriuretic peptide (CNP) on atrial dynamics and hypoxia inducible factor 1 alpha (HIF-1α) activity in perfused beating rat atria, under hypoxic conditions. Hypoxia significantly increased the levels of HIF-1α, concomitant with decreased trial dynamics. CNP (0.1 μmol/L) further decreased atrial dynamics under hypoxia and suppressed hypoxia-induced stimulation of HIF-1α expression. An adenylylcyclase (AC) activator, forskolin (0.1 μmol/L), significantly up-regulated atrial phosphodiesterase subtype 3A (PDE 3A) protein without affecting hypoxia-induced dynamics. In the presence of forskolin, the inhibitory effects of CNP on hypoxia-induced atrial dynamics and HIF-1α levels were significantly attenuated. Forskolin also prevented hypoxia-induced downregulation of PDE3A protein. These findings suggested that CNP inhibited atrial dynamics and HIF-1α activity in the isolated perfused beating rat atria under hypoxic conditions. Furthermore, both effects were modulated by the AC activator forskolin, through activation of CNP-PDE 3A signaling.